5-amino 1MQ

Source / Derivation:

5-amino-1-methylquinolinium (5-amino 1MQ) is a small molecule peptide analog designed to modulate NAD+-dependent metabolic pathways. It is studied for its role in cellular energy regulation, mitochondrial function, and metabolic efficiency.

5-amino 1MQ

Mechanism of Action:

5-amino 1MQ functions as an inhibitor of nicotinamide N-methyltransferase (NNMT), a key enzyme involved in NAD+ metabolism and cellular energy regulation. By modulating NNMT activity, it can influence lipid and glucose metabolism, as well as mitochondrial bioenergetics.

Clinical Relevance & Potential Outcomes:

Preclinical studies indicate that 5-amino 1MQ may support enhanced metabolic efficiency, improved energy utilization, and potential reductions in adiposity. It has been explored for applications in metabolic disorders, weight management, and age-related declines in mitochondrial function.

Intended Clinical Application:

5-amino 1MQ may be relevant for patients seeking metabolic optimization, support for mitochondrial function, or adjunctive therapy for metabolic dysregulation.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

33 mg/ml, total 3 ml, total 100 mg

Daily

1 month

Metabolism-boosting NNMT inhibitor that supports cellular energy, enhances fat-burning efficiency, improves insulin sensitivity, and promotes healthier mitochondrial and metabolic function.